Sabby Management, LLC Xenetic Biosciences, Inc. Transaction History

Sabby Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$0.71 - $1.31 $42,971 - $79,285	-60,523 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$0.49 - $1.69 $100,437 - $346,407	-204,975 Reduced 77.2%	60,523 $45,000
Q4 2019 Feb 14, 2020	SELL	$1.05 - $1.66 $146,004 - $230,826	-139,052 Reduced 34.37%	265,498 $382,000
Q3 2019 Nov 15, 2019	BUY	$1.2 - $12.7 $485,460 - $5.14 Million	404,550 New	404,550 $484,000

Ticker XBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,166,600
Market Cap $64.6M
Description
Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the discovery, research, and development of biologic drugs and oncology therapeutics. It advances cell-base...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.